Back to search

Article

The Impact of CARA Mandates on Nurse Practitioner Controlled Substance Prescribing in Oregon: A Cohort Study

2021-09-20

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> In 2017, the United States Comprehensive Addiction and Recovery Act (CARA) expanded authorization to prescribe buprenorphine for opioid use disorder to nurse practitioners (NPs). In contrast to physicians, NPs were required to complete 16 additional hours of training on controlled substance prescribing before a buprenorphine waiver application. As this different...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4508e9a7-ca1d-5555-8112-6bf90093223c
DOI
10.21203/rs.3.rs-892559/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Impact of CARA Mandates on Nurse Practitioner Controlled Substance Prescribing in Oregon: A Cohort StudyDOI 10.21203/rs.3.rs-892559/v1
The effects of a provincial opioid prescribing standard on opioid prescribing for pain: interrupted series analysisSemantic proximity
Experiences of Opioid Use and Perceptions of Medication-Assisted Treatment (MAT) in Oakland's Safety Net Clinics Amid the COVID-19 PandemicSemantic proximity
Pronounced State Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019-2020)Semantic proximity
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiencesSemantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
National Increase but Pronounced Regional Disparities in Naloxone Prescribing to United States Medicaid and Medicare PatientsSemantic proximity
Disparities in Naltrexone Prescriptions to Medicaid Enrollees During the COVID-19 PandemicSemantic proximity
“The DEA Would Come In And Destroy You”: A Qualitative Study of Fear And Unintended Consequences Emerging From Restrictive Opioid Prescribing Policies In West VirginiaSemantic proximity
Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPPSemantic proximity
“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatmentSemantic proximity
General practice patients starting treatment for substance use problems: observations from two data sources across levels of careSemantic proximity
Select a neighboring publication to make it the new centre.